Precision care for pulmonary fibrosis in Ireland
Part of Genetic & congenital, Lungs & breathing, Skin clinical trials.
This trial is for people with scarring lung disease (pulmonary fibrosis) in Ireland. It aims to better understand and care for the condition, especially in families. The study will look at medical data and may help improve diagnosis and treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a type of scarring lung disease (fibrotic ILD) diagnosed by a team of doctors.
- Your lung disease must fall into one of these groups: (a) you have a blood relative with scarring lung disease, (b) you have IPF (a specific type) without a family history, or (c) you have a connective tissue disease like rheumatoid arthritis, scleroderma, Sjogren's, myositis, or lupus.
- You must be willing to give written permission to join the study.
- You cannot be in another clinical trial that tests a treatment right now.
- Your lung scarring should not be caused by an allergy (like mold or birds) or by asbestos exposure.
- Your doctor must expect you to live longer than 12 months, based on your overall health.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for people with a specific type of lung scarring (not IPF) to understand how the disease progresses. Researchers will collect detailed health information, imaging, and blood samples to learn more about the condition.
This study is testing a new way to track lung scarring (fibrosis) over time in people with conditions like IPF, other fibrotic lung diseases, or early signs of scarring. It might help doctors understand how the disease changes.
This study sets up an international registry to follow people with newly diagnosed fibrotic interstitial lung disease (lung scarring). It uses eHealth technology (an online/app-based system) so your team can better understand your condition over time and improve future care.
This study builds a community registry to learn about people affected by pulmonary fibrosis and related lung conditions, including patients, caregivers, and close family. By joining, you help researchers better understand needs and experiences in the real world.
This trial studies whether using a home monitoring program helps people with pulmonary fibrosis track their condition. It aims to make care easier and catch changes early.
This study looks at genetic differences in people with idiopathic pulmonary fibrosis (a lung scarring condition with no known cause). It may help researchers understand what influences the disease and guide future treatment options.
Hear when a new Connective Tissue Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.